weight loss on compounded semaglutide NYC Woman shares journey of weight
Description
Hair loss observed during semaglutide treatment stems primarily from telogen effluvium, a temporary condition where hair follicles shift into a resting phase due to physical or metabolic stress
Not a rough estimate
Contrary to popular belief, GLP-1 receptor agonists do not function as metabolic stimulants or significantly increase resting metabolic rate
Muscle mass loss during GLP-1 receptor agonist therapy prevented with GDF8 and activin A blockade
No liver/kidney toxicity in studies
